In a study of 240 BCP-ALL by Ding et al., TP53 mutations were only observed in 5 cases [3]; and no genomic gain or loss of TP53 was detected in another independent cohort of 192 BCP-ALL [18]. The gene discussed is TP53; the disease is acute lymphoblastic leukemia.